China Growth Stocks

[GorillaGorilla]

SKBI - in line with expectations guidance same.

NAZ stock with adjusted Earnings $1.82
Even if you divide entire years earnings by 7 million outstanding you end up with 1.38 and then throw in 15% growth you end up with $20 stock - they are guiding 30% plus evaulation in second half of the year - basically when the vaccine facility is running (large increase of revenue on a high margin product).

Imp bits - demand outweights supply and very bullish comment:

Demand for Skystar's products currently outweigh supply, and our recently completed micro-organism facility, as well as the new vaccine manufacturing facility being constructed and certified in accordance with GMP standards, will propel Skystar into a new era of growth


Intreging bit:

"As of December 31, 2009, Skystar has made deposits for 2 potential acquisitions for a total deposit amount of $6,802,704 (RMB 46,400,000). Due diligence of these targets are currently under way. We anticipate that these acquisitions would be treated as asset purchases. The acquisition targets are being reviewed under confidentiality agreements; however, we note that an appraisal report was obtained in January 2010 for one of the targets and we expect to complete our due diligence by June 2010. The targets in question were selected because of the ability to achieve GMP certifications quickly," concluded Mr. Lu.


http://finance.yahoo.com/news/Skystar-BioPharmaceutical-iw-2646065649.html?x=0&.v=1

If I was a betting man I reckon there will be a mild sell off after the run up into the quieter Q1 & Q2 quarters. I'm holding.


rich